Cue Biopharma (CUE) EV to FCF (2018 - 2025)

Cue Biopharma has disclosed EV to FCF across 8 years of filings, most recently posting 795.4 for Q4 2025.

• In Q4 2025, EV to FCF fell 259.47% year-over-year to 795.4; the TTM figure through Dec 2025 stood at 39.14 (up 28.7% YoY), while the FY2025 annual figure was 39.14, up 28.7% from the prior year.
• EV to FCF came in at 795.4 for Q4 2025 at Cue Biopharma, down from 239.03 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 177.37 in Q3 2024 to a low of 2054.32 in Q3 2021.
• Average EV to FCF over 5 years is 521.83, with a median of 364.5 recorded in 2023.
• Year-over-year, EV to FCF tumbled 1099.34% in 2021 and soared 83.83% in 2022.
• Over 5 years, EV to FCF stood at 1020.36 in 2021, then soared by 72.3% to 282.62 in 2022, then dropped by 19.17% to 336.8 in 2023, then surged by 34.3% to 221.27 in 2024, then slumped by 259.47% to 795.4 in 2025.
• Per Business Quant data, the three most recent EV to FCF figures were 795.4 in Q4 2025, 239.03 in Q3 2025, and 446.29 in Q2 2025.